Jade Biosciences

JBIO

Market cap $1.25B

58 hedge funds and large institutions have $386M invested in Jade Biosciences in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New

Increased

Maintained

Reduced

Closed

83% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 12

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

0.01% less ownership

Funds ownership: 2.95% → 2.94% (-0.01%)

2% less funds holding

Funds holding: 59 → 58 (-1)

21% less capital invested

Capital invested by funds: $488M → $386M (-$102M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders

Holders Change

-1

Holders Change %

-1.69%

% of All Funds

0.92%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.08%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

1	FLSM Frazier Life Sciences Management Palo Alto, California	+$3.25M
2	GPP Great Point Partners Greenwich, Connecticut	+$2.46M
3	SCM Silverarc Capital Management Boston, Massachusetts	+$1.55M
4	Vanguard Group Malvern, Pennsylvania	+$1.17M
5	BlackRock New York	+$931K

Top Sellers

1	Citadel Advisors Miami, Florida	-$5.01M
2	Fidelity Investments Boston, Massachusetts	-$3.07M
3	OCA Octagon Capital Advisors New York	-$1.92M
4	HS HighVista Strategies Boston, Massachusetts	-$717K
5	FAM Fred Alger Management New York	-$513K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	RCM 1 RA Capital Management Boston, Massachusetts	$112M	–	–	–
2	SI 2 Sofinnova Investments Menlo Park, California	$51M	–	–	–
3	TCM 3 TCG Crossover Management Palo Alto, California	$29.9M	–	–	–
4	AVLSA 4 Atlas Venture Life Science Advisors Cambridge, Massachusetts	$27.7M	–	–	–
5	BBA 5 Baker Bros. Advisors New York	$26.6M	–	–	–
6	CAM 6 Cormorant Asset Management Boston, Massachusetts	$21.2M	–	–	–
7	FLSM 7 Frazier Life Sciences Management Palo Alto, California	$16.4M	+$3.25M	+6,000	+21%
8	DCM 8 Driehaus Capital Management Chicago, Illinois	$16.1M	-$100K	-185	-0.5%
9	GPP 9 Great Point Partners Greenwich, Connecticut	$14.8M	+$2.46M	+4,545	+17%
10	O 10 OrbiMed New York	$10.3M	–	–	–
11	11 BlackRock New York	$9.27M	+$931K	+1,718	+10%
12	OMC 12 OUP Management Company Bala Cynwyd, Pennsylvania	$8.19M	–	–	–
13	13 Vanguard Group Malvern, Pennsylvania	$8.13M	+$1.17M	+2,158	+14%
14	14 Fidelity Investments Boston, Massachusetts	$7.19M	-$3.07M	-5,659	-27%
15	OCA 15 Octagon Capital Advisors New York	$6.75M	-$1.92M	-3,552	-20%
16	16 Geode Capital Management Boston, Massachusetts	$3.39M	+$723K	+1,335	+23%
17	GTC 17 Ghost Tree Capital New York	$2.73M	–	–	–
18	18 State Street Boston, Massachusetts	$2.46M	-$114K	-210	-4%
19	19 Northern Trust Chicago, Illinois	$1.5M	+$348K	+642	+26%
20	SCM 20 Silverarc Capital Management Boston, Massachusetts	$1.36M	+$1.55M	+2,857	New
21	NCM 21 Nantahala Capital Management New Canaan, Connecticut	$1.29M	–	–	–
22	22 Millennium Management New York	$724K	+$309K	+571	+60%
23	23 Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden	$690K	–	–	–
24	EP 24 Eversept Partners New York	$682K	–	–	–
25	NFGH 25 Nan Fung Group Holdings Kai Tak, Hong Kong	$650K	–	–	–